Private equity deal volume shows unprecedented divergence in 2026, with some firms cutting activity 75-95% from 2021 peaks while others double investment allocations. Tiger Global and SoftBank Vision Fund lead the retreat, while Forbion Capital has doubled down on biotech sectors.
The bifurcation mirrors broader market positioning ahead of projected turbulence. Analysts forecast the S&P 500 could decline to 3,500 by 2028, driving defensive repositioning across the sector. Despite caution, major transactions continue: Keurig Dr Pepper pursues JDE Peet's acquisition while Oak-Eagle AcquireCo launched tender offers independent of merger conditions.
Sector-specific investment trends drive the split strategy. Biotech attracted concentrated capital from firms like Forbion, which sees opportunity in market dislocation. Industrial real estate also draws investment, with Corniche Capital announcing up to 400,000 square feet of build-to-suit space in New Mexico targeting food storage, defense manufacturing, and data centers.
"Los Lunas sits at the center of everything industrial tenants need right now: power, transportation, labor, and a state government that actively wants to help businesses grow," said David Ebrahimzadeh of Corniche Capital, citing cost-effective economic incentives.
Private equity firms face mounting pressure from private credit market exposure. The asset class grew rapidly during low-rate years but now risks defaults as refinancing costs surge. Firms with heavy private credit allocations could face portfolio writedowns if credit markets deteriorate alongside projected equity declines.
Onex reports "significant momentum heading into the new year" with confidence extending to 2026 and beyond, according to Bobby Le Blanc. However, overall sentiment remains mixed as firms execute corporate separations and strategic pivots to navigate anticipated volatility.
Sentiment trajectory is deteriorating. Deal activity concentration in defensive sectors and operational improvements suggests private equity is preparing for extended market weakness rather than near-term recovery.